Streptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infections.
Osowicki, J.; Frost, H. R.; Azzopardi, K. I.; Whitcombe, A. L.; McGregor, R.; Carlton, L. H.; Baker, C.; Fabri, L.; Pandey, M.; Good, M. F.; Carapetis, J. R.; Walker, M. J.; Smeesters, P. R.; Licciardi, P. V.; Moreland, N. J.; Hill, D. L.; Steer, A. C.
Show abstract
Knowledge gaps regarding human immunity to Streptococcus pyogenes have impeded vaccine development. To address these gaps and evaluate vaccine candidates, we established a human challenge model of S. pyogenes pharyngitis. Here, we analysed antibody responses in serum and saliva against 19 antigens to identify characteristics distinguishing 19 participants who developed pharyngitis and 6 who did not. Pharyngitis elicited serum IgG responses to key vaccine antigens and a muted mucosal IgA response, whereas the 6 participants without pharyngitis had more pronounced IgA responses and minimal IgG responses. Serum IgG responses to pharyngitis in adult participants resembled those observed in children and were inversely correlated with the magnitude of pre-existing responses. While a straightforward correlate of protection was not evident, baseline antibody signatures distinguished clinical and immunological outcomes following experimental challenge. This highlights the influence of a complex humoral imprint from previous exposure, relevant for interpreting immunogenicity in forthcoming vaccine trials.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Elevated mucosal antibody responses against SARS-CoV-2 are correlated with lower viral load and faster decrease in systemic COVID-19 symptoms 96%
- Gut bacteria-derived sphingolipids alter innate immune responses to oral cholera vaccine antigens 95%
- Seven-month kinetics of SARS-CoV-2 antibodies and protective role of pre-existing antibodies to seasonal human coronaviruses on COVID-19 95%
Similar papers in this journal
- Vaccine-induced, but not natural immunity, against the Streptococcal Inhibitor of Complement protects against invasive disease 94%
- Virus-like particle vaccines targeting a key epitope in circumsporozoite protein provide sterilizing immunity against malaria 93%
- A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses 93%
Similar papers in this journal
- Class switch towards non-inflammatory IgG isotypes after repeated SARS-CoV-2 mRNA vaccination 95%
- Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues 93%
- Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5 93%
Similar papers in this journal
- Immune and behavioral correlates of protection against symptomatic post-vaccination SARS-CoV-2 infection 95%
- Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders 94%
- Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD-20 therapy 94%
Similar papers in this journal
- COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection 95%
- Non-severe SARS-CoV-2 infection is characterised by very early T cell proliferation independent of type 1 interferon responses and distinct from other acute respiratory viruses 94%
- Rewired type I IFN signaling is linked to age-dependent differences in COVID-19 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.